Medinova Diagnostic Services Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Medinova Diagnostic Services has been growing earnings at an average annual rate of 16.8%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 1.8% per year.
Wichtige Informationen
16.8%
Wachstumsrate der Gewinne
17.0%
EPS-Wachstumsrate
| Healthcare Wachstum der Industrie | 29.4% |
| Wachstumsrate der Einnahmen | 1.8% |
| Eigenkapitalrendite | n/a |
| Netto-Marge | 19.4% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Medinova Diagnostic Services Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 99 | 19 | 6 | 0 |
| 30 Jun 24 | 102 | 21 | 0 | 0 |
| 31 Mar 24 | 102 | 20 | 6 | 0 |
| 31 Dec 23 | 104 | 22 | 5 | 0 |
| 30 Sep 23 | 103 | 20 | 5 | 0 |
| 30 Jun 23 | 99 | 17 | 0 | 0 |
| 31 Mar 23 | 100 | 17 | 5 | 0 |
| 31 Dec 22 | 99 | 12 | 2 | 0 |
| 30 Sep 22 | 103 | 14 | 2 | 0 |
| 30 Jun 22 | 111 | 15 | 2 | 0 |
| 31 Mar 22 | 132 | 23 | 2 | 0 |
| 31 Dec 21 | 133 | 25 | 2 | 0 |
| 30 Sep 21 | 144 | 30 | 2 | 0 |
| 30 Jun 21 | 157 | 31 | 2 | 0 |
| 31 Mar 21 | 127 | 20 | 2 | 0 |
| 31 Dec 20 | 119 | 16 | 2 | 0 |
| 30 Sep 20 | 99 | 7 | 2 | 0 |
| 30 Jun 20 | 71 | -2 | 0 | 0 |
| 31 Mar 20 | 74 | -3 | 2 | 0 |
| 31 Dec 19 | 79 | 10 | 3 | 0 |
| 30 Sep 19 | 81 | 7 | 3 | 0 |
| 30 Jun 19 | 88 | 9 | 0 | 0 |
| 31 Mar 19 | 90 | 8 | 3 | 0 |
| 31 Dec 18 | 90 | 4 | 6 | 0 |
| 30 Sep 18 | 93 | 4 | 6 | 0 |
| 30 Jun 18 | 90 | 3 | 0 | 0 |
| 31 Mar 18 | 87 | -5 | 6 | 0 |
| 31 Dec 17 | 84 | -6 | 5 | 0 |
| 30 Sep 17 | 82 | -13 | 5 | 0 |
| 30 Jun 17 | 80 | -15 | 5 | 0 |
| 31 Mar 17 | 78 | -17 | 8 | 0 |
| 31 Dec 16 | 90 | -27 | 6 | 0 |
| 30 Sep 16 | 93 | -25 | 6 | 0 |
| 30 Jun 16 | 91 | -20 | 0 | 0 |
| 31 Mar 16 | 81 | -19 | 6 | 0 |
| 31 Dec 15 | 72 | -38 | 6 | 0 |
| 30 Sep 15 | 67 | -33 | 6 | 0 |
| 30 Jun 15 | 70 | -36 | 6 | 0 |
| 31 Mar 15 | 77 | -36 | 6 | 0 |
| 31 Dec 14 | 83 | -9 | 45 | 12 |
| 30 Sep 14 | 94 | -7 | 45 | 12 |
| 30 Jun 14 | 101 | -3 | 0 | 0 |
| 31 Mar 14 | 111 | 0 | 45 | 12 |
| 31 Dec 13 | 123 | -2 | 50 | 12 |
Qualität der Erträge: 526301 has high quality earnings.
Wachsende Gewinnspanne: 526301's current net profit margins (19.4%) are lower than last year (19.5%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 526301's earnings have grown by 16.8% per year over the past 5 years.
Beschleunigtes Wachstum: 526301's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: 526301 had negative earnings growth (-4.1%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 526301's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.